Stefan Schulz Selected Research

Stefan Schulz Research Topics

Disease

45	Neoplasms (Cancer) 11/2023 - 11/2003
17	Pain (Aches) 11/2023 - 12/2006
13	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2023 - 11/2008
7	Inflammation (Inflammations) 01/2022 - 12/2006
6	Pituitary Neoplasms (Pituitary Adenoma) 06/2023 - 10/2006
5	Adenoma (Adenomas) 11/2013 - 04/2008
4	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2018
4	Opioid-Related Disorders (Opiate Addiction) 01/2021 - 05/2004
4	Carcinoma (Carcinomatosis) 09/2015 - 09/2006
4	Carcinoid Tumor (Carcinoid) 03/2015 - 02/2009
3	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 11/2009
3	Acromegaly 06/2023 - 02/2009
3	Constipation 01/2020 - 01/2018
3	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2009
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2018 - 11/2011
3	Dehydration (Water Stress) 01/2017 - 11/2002
3	Arthritis (Polyarthritis) 07/2014 - 06/2011
3	Hyperalgesia 07/2014 - 06/2011
3	Growth Hormone-Secreting Pituitary Adenoma 11/2013 - 04/2008
2	Rectal Neoplasms (Rectal Cancer) 11/2023 - 01/2023
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2021
2	Chronic Pain 01/2020 - 01/2018
2	Adenocarcinoma 10/2019 - 10/2018
2	Lymphoma (Lymphomas) 01/2017 - 11/2016
2	Astrocytoma (Pilocytic Astrocytoma) 08/2013 - 01/2004
2	Bites and Stings (Sting) 09/2010 - 01/2004
2	Pituitary ACTH Hypersecretion 02/2010 - 02/2009
2	Brain Ischemia (Cerebral Ischemia) 07/2008 - 07/2002
2	Pheochromocytoma 06/2008 - 11/2003
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2006 - 09/2006
2	Glioblastoma (Glioblastoma Multiforme) 09/2006 - 01/2004
2	Ischemia 12/2004 - 07/2002
1	Hypoxia (Hypoxemia) 01/2024
1	COVID-19 01/2024
1	Cushing Syndrome 06/2023
1	Substance-Related Disorders (Drug Abuse) 01/2023
1	Myocardial Infarction 11/2022
1	Thyroid Neoplasms (Thyroid Cancer) 07/2022
1	Follicular Adenocarcinoma 07/2022
1	Anaplastic Thyroid Carcinoma 07/2022
1	Malaria 01/2021
1	Hemolysis 01/2021
1	Glaucoma 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Neuroendocrine Carcinoma 09/2020

Drug/Important Bio-Agent (IBA)

32	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2023 - 11/2003
29	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2023 - 03/2002
15	Chemokine ReceptorsIBA 07/2022 - 07/2002
14	Monoclonal AntibodiesIBA 07/2022 - 01/2008
13	Opioid Analgesics (Opioids)IBA 11/2023 - 01/2005
11	Proteins (Proteins, Gene)FDA Link 04/2015 - 11/2002
9	Octreotide (Sandostatin)FDA LinkGeneric 06/2023 - 11/2003
9	somatostatin receptor 2IBA 11/2016 - 12/2004
8	Opioid Receptors (Opioid Receptor)IBA 01/2020 - 12/2006
7	GTP-Binding Proteins (G-Protein)IBA 01/2023 - 08/2012
7	LigandsIBA 01/2022 - 12/2004
7	ParaffinIBA 10/2017 - 09/2006
7	AntibodiesIBA 11/2016 - 11/2003
7	Formaldehyde (Formol)FDA Link 03/2015 - 09/2006
6	Messenger RNA (mRNA)IBA 03/2015 - 09/2005
5	pasireotideIBA 06/2023 - 02/2009
5	CXCR4 Receptors (CXCR4 Receptor)IBA 07/2022 - 01/2008
5	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 09/2011
5	ChemokinesIBA 10/2019 - 12/2006
5	somatostatin receptor type 1IBA 12/2017 - 08/2011
4	Peptides (Polypeptides)IBA 10/2006 - 12/2004
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2012
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 10/2006
3	Analgesics (Analgesic Drugs)IBA 01/2020 - 03/2015
3	AntigensIBA 07/2014 - 06/2011
2	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2023 - 11/2014
2	Opioid Peptides (Opioid Peptide)IBA 01/2021 - 12/2006
2	Endothelin A ReceptorIBA 07/2018 - 10/2017
2	Endothelins (Endothelin)IBA 07/2018 - 06/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 08/2011 - 06/2011
2	Chemokine CXCL12IBA 01/2011 - 07/2002
2	Membrane Proteins (Integral Membrane Proteins)IBA 06/2010 - 11/2002
2	Protein Isoforms (Isoforms)IBA 07/2009 - 07/2002
1	Indicators and Reagents (Reagents)IBA 01/2024
1	Oxygen (Dioxygen)IBA 01/2024
1	CYM51010IBA 01/2023
1	propionamideIBA 01/2023
1	Carvedilol (Coreg)FDA LinkGeneric 11/2022
1	6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA 01/2022
1	ArrestinIBA 07/2021
1	CannabinoidsIBA 01/2021
1	Complement C5a (Complement 5a)IBA 01/2021
1	Volatile Organic CompoundsIBA 01/2021
1	Acyl-ButyrolactonesIBA 01/2021
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Odorant Receptors (Odorant Receptor)IBA 01/2021
1	Anaphylatoxin C5a ReceptorIBA 01/2021
1	NociceptinIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021

Therapy/Procedure

12	Therapeutics 11/2023 - 12/2005
6	Analgesia 07/2021 - 12/2006
2	Neoadjuvant Therapy 11/2023 - 01/2023
2	Radiotherapy 01/2012 - 10/2006